Acelrx Pharmaceuticals reported $6.82M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 6.82M 516K
Baxter International BAX:US $ 817M 27M
Becton, Dickinson and BDX:US $ 1.15B 83M
Cara Therapeutics CARA:US $ 7.54M 1.78M
Heron Therapeutics HRTX:US $ 32.12M 836K
Intra Cellular Therapies ITCI:US $ 100.32M 24.86M
Johnson & Johnson JNJ:US $ 6.23B 288M
Pain Therapeutics PTIE:US $ 2.97M 54K
Pfizer PFE:US $ 3.2B 506M
Smiths SMIN:LN 267M 19M
Teva Pharmaceutical TEVA:IT 849M 30M
Xeris Pharmaceuticals Inc XERS:US $ 32.98M 5.67M